Five Companies Refuse to Delist FTC-Challenged Orange Book Patents, Three Others Comply
While three of the companies warned of inappropriate Orange Book patent listings by the FTC are delisting all the challenged patents, according to the U.S. legislators who led the action, five others refused to delist.
Source: Drug Industry Daily